Skip to content

Clinical trials

Genetic Diseases, Inborn trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: Spain Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20113
20132
20142
20152
20163
20173
20187
20195
20202
20218
20224
20234
20244
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting12
Active, not recruiting8
Terminated7
Enrolling by invitation5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company7
BioMarin Pharmaceutical5
ModernaTX, Inc.5
Novartis Pharmaceuticals4
Novo Nordisk A/S3
Pfizer3
Alexion Pharmaceuticals, Inc.2
Asociación Española para el Estudio del Hígado2
Genzyme, a Sanofi Company2
PTC Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn59
Musculoskeletal Diseases17
Bone Diseases11
Nervous System Diseases11
Osteochondrodysplasias11
Dwarfism10
Mucopolysaccharidosis IV8
Achondroplasia7
Hematologic Diseases7
Metabolism, Inborn Errors7

Trials

Showing 76 to 59 of 59. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.